🇺🇸 FDA
Patent

US 6599884

Processes for preparing clarithromycin polymorphs and novel polymorph IV

expired A61PA61P31/04

Quick answer

US patent 6599884 (Processes for preparing clarithromycin polymorphs and novel polymorph IV) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61P, A61P31/04